Advertisement

Tumor Biology

, Volume 35, Issue 3, pp 2359–2366 | Cite as

Association between glutathione S-transferase T1 null genotype and risk of lung cancer: a meta-analysis of 55 studies

  • Hongmei Yang
  • Xiaoyu Shen
  • Binru Li
  • Rui Ma
Research Article

Abstract

The relationship between glutathione S-transferase T1 (GSTT1) gene polymorphism and the risk of lung cancer from the published reports are still conflicting. This study was conducted to evaluate the relationship between GSTT1 polymorphism and the risk of lung cancer. A comprehensive research was conducted through the databases, and 55 studies were recruited into this meta-analysis for the association of null genotype of GSTT1 with lung cancer susceptibility, consisting of 15,140 patients with lung cancer and 16,662 controls. There was a significant association between GSTT1 null genotype and lung cancer risk in the overall populations (OR = 1.138, 95 % CI = 1.032–1.255, P heterogeneity = 0.000, P = 0.009). Furthermore, GSTT1 null genotype was associated with the lung cancer risk in Asians (OR = 1.469, 95 % CI = 1.228–1.757, P heterogeneity = 0.000, P = 0.000). However, GSTT1 null genotype was not associated with the risk of lung cancer in Caucasians and Africans. In conclusion, GSTT1 null genotype is associated with the lung cancer in overall populations and in Asians.

Keywords

Lung cancer Glutathione S-transferase T1 Susceptibility Polymorphism Meta-analysis 

Notes

Conflicts of interest

None

References

  1. 1.
    Khuri FR, Herbst RS, Fossella FV. Emerging therapies in non-small cell lung cancer. Ann Oncol. 2001;12:739–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer. 2000;27:3–18.PubMedCrossRefGoogle Scholar
  3. 3.
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;14:1194–210.CrossRefGoogle Scholar
  5. 5.
    Strange RC, Fryer AA. The glutathione-S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ. 1999;148:231–49.PubMedGoogle Scholar
  6. 6.
    Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 2001;174:35–44.PubMedCrossRefGoogle Scholar
  7. 7.
    Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasians non-smokers: a pooled analysis. Carcinogenesis. 2003;24:875–82.PubMedCrossRefGoogle Scholar
  8. 8.
    Du Y, Wang H, Fu X, Sun R, Liu Y. GSTT1 null genotype contributes to coronary heart disease risk: a meta-analysis. Mol Biol Rep. 2012;39:8571–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Xue H, Su J, Sun K, Xie W, Wang H. Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis. Mol Biol Rep. 2012;39:5033–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Dusinska M, Staruchova M, Horska A, Smolkova B, Collins A, Bonassi S, et al. Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res. 2012;736:130–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Oliveira C, Lourenco GJ, Sagarra RA, Derchain SF, Segalla JG, Lima CS. Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk. Dis Markers. 2012;33:155–9.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Atinkaya C, Taspinar M, Sakiragaoglu O, Oz G, Yazici U, Oztuna D, et al. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case–control study. Hum Exp Toxicol. 2012;31:1074–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Mondal R, Ghosh SK, Talukdar FR, Laskar RS. Association of mitochondrial D-loop mutations with GSTM1 and GSTT1 polymorphisms in oral carcinoma: a case control study from northeast India. Oral Oncol. 2013;49:345–53.PubMedCrossRefGoogle Scholar
  14. 14.
    Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Jourenkova N, Reinikanen M, Bouchardy C, Husgafvel-Pursiainen K, Dayer P, Benhamou S, et al. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics. 1997;7:515–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer. 1998;77:516–21.PubMedCrossRefGoogle Scholar
  17. 17.
    To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Carrasco JL, et al. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control. 1999;10:65–70.PubMedCrossRefGoogle Scholar
  18. 18.
    Lan Q, He X, Costa DJ, Tian L, Rothman N, Hu G, et al. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case–control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev. 2000;9:605–8.PubMedGoogle Scholar
  19. 19.
    Malats N, Camus-Radon AM, Nyberg F, Ahrens W, Constantinescu V, Mukeria A, et al. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev. 2000;9:827–33.PubMedGoogle Scholar
  20. 20.
    Kiyohara C, Yamamura KI, Nakanishi Y, Takayama K, Hara N. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pac J Cancer Prev. 2000;1:293–8.PubMedGoogle Scholar
  21. 21.
    Spitz MR, Duphorne CM, Detry MA, Pillow PC, Amos CI, Lei L, et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:1017–20.PubMedGoogle Scholar
  22. 22.
    Hou SM, Falt S, Nyberg F. Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk. Environ Mol Mutagen. 2001;38:83–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, et al. Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev. 2001;10:1063–7.PubMedGoogle Scholar
  24. 24.
    Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics. 2001;11:757–64.PubMedCrossRefGoogle Scholar
  25. 25.
    Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res. 2001;61:8718–22.PubMedGoogle Scholar
  26. 26.
    Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev. 2002;11:730–8.PubMedGoogle Scholar
  27. 27.
    Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 2002;180:165–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Stucker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cenee S, et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis. 2002;23:1475–81.PubMedCrossRefGoogle Scholar
  29. 29.
    Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, Eaton DL. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer. 2003;40:247–58.PubMedCrossRefGoogle Scholar
  30. 30.
    Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett. 2003;201:185–93.PubMedCrossRefGoogle Scholar
  31. 31.
    Ruano-Ravina A, Figueiras A, Loidi L, Barros-Dios JM. GSTM1 and GSTT1 polymorphisms, tobacco and risk of lung cancer: a case–control study from Galicia, Spain. Anticancer Res. 2003;23:4333–7.PubMedGoogle Scholar
  32. 32.
    Sorensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer. 2004;110:219–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Schneider J, Bernges U, Philipp M, Woitowitz HJ. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett. 2004;208:65–74.PubMedCrossRefGoogle Scholar
  34. 34.
    Belogubova EV, Togo AV, Karpova MB, Kuligina E, Buslova KG, Ulibina JM, et al. A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referents. Lung Cancer. 2004;43:259–66.PubMedCrossRefGoogle Scholar
  35. 35.
    Alexandrie AK, Nyberg F, Warholm M, Rannug A. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev. 2004;13:908–14.PubMedGoogle Scholar
  36. 36.
    Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis. 2004;25:1935–44.PubMedCrossRefGoogle Scholar
  37. 37.
    Chan-Yeung M, Tan-Un KC, Ip MS, Tsang KW, Ho SP, Ho JC, et al. Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer. 2004;45:155–60.PubMedCrossRefGoogle Scholar
  38. 38.
    Liang GY, Pu YP, Yin LH. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Yi Chuan. 2004;26:584–8.PubMedGoogle Scholar
  39. 39.
    Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem. 2004;266:1–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, et al. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene–gene interactions. Biomarkers. 2004;9:298–305.PubMedCrossRefGoogle Scholar
  41. 41.
    Wang LI, Giovannucci EL, Hunter D, Neuberg D, Su L, Christiani DC. Dietary intake of cruciferous vegetables, glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control. 2004;15:977–85.PubMedCrossRefGoogle Scholar
  42. 42.
    Gallegos-Arreola MP, Gomez-Meda BC, Morgan-Villela G, Arechavaleta-Granell MR, Arnaud-Lopez L, Beltran-Jaramillo TJ, et al. GSTT1 gene deletion is associated with lung cancer in Mexican patients. Dis Markers. 2003;19:259–61.PubMedCrossRefGoogle Scholar
  43. 43.
    Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 2005;26:395–401.PubMedCrossRefGoogle Scholar
  44. 44.
    Cote ML, Kardia SL, Wenzlaff AS, Land SJ, Schwartz AG. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis. 2005;26:811–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Syamala VS, Sreeja L, Syamala V, Raveendran PB, Balakrishnan R, Kuttan R, et al. Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam Cancer. 2008;7(3):213–20.PubMedCrossRefGoogle Scholar
  46. 46.
    Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, et al. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a Mendelian randomisation approach. Lancet. 2005;366:1558–60.PubMedCrossRefGoogle Scholar
  47. 47.
    Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis. 2006;27:525–32.PubMedCrossRefGoogle Scholar
  48. 48.
    Chen HC, Cao YF, Hu WX, Liu XF, Liu QX, Zhang J, et al. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Dis Markers. 2006;22:141–52.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Lee KM, Kang D, Lee SJ, Park SK, Lee KH, Choi JY, et al. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep. 2006;16:1035–9.PubMedGoogle Scholar
  50. 50.
    Reszka E, Wasowicz W, Gromadzinska J. Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: results of lung cancer case–control study. Gene Nutr. 2007;2:287–94.CrossRefGoogle Scholar
  51. 51.
    Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer. 2007;57:135–42.PubMedCrossRefGoogle Scholar
  52. 52.
    Loft S, Svoboda P, Kasai H, Tjonneland A, Moller P, Sorensen M, et al. Prospective study of urinary excretion of 7-methyl-guanine and the risk of lung cancer: effect modification by mu class glutathione-S-transferases. Int J Cancer. 2007;121:1579–84.PubMedCrossRefGoogle Scholar
  53. 53.
    Honma HN, De Capitani EM, Jr Perroud MW, Barbeiro AS, Toro IF, Costa DB, et al. Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer. 2008;61:152–62.PubMedCrossRefGoogle Scholar
  54. 54.
    Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, et al. Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. Biomarkers. 2008;13:282–95.PubMedCrossRefGoogle Scholar
  55. 55.
    Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, et al. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. J Exp Ther Oncol. 2008;7:73–85.PubMedGoogle Scholar
  56. 56.
    Kumar M, Agarwal SK, Goel SK. Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem. 2009;322:73–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Altinisik J, Balta ZB, Aydin G, Ulutin T, Buyru N. Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep. 2010;37:263–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Cabral RE, Caldeira-de-Araujo A, Cabral-Neto JB, Costa CMG. Analysis of GSTM1 and GSTT1 polymorphisms in circulating plasma DNA of lung cancer patients. Mol Cell Biochem. 2010;338:263–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Gervasini G, San JC, Carrillo JA, Benitez J, Cabanillas A. GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high-incidence area. Nutr Cancer. 2010;62:750–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Sreelekha TT, Rajesh M, Anil KV, Madhavan J, Balaram P. CYP1A1m2 polymorphisms regulate estrogen and interleukin-6 in lung cancer. Mol Med Rep. 2010;3:971–6.PubMedGoogle Scholar
  61. 61.
    Tamaki Y, Arai T, Sugimura H, Sasaki T, Honda M, Muroi Y, et al. Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug Metab Pharmacokinet. 2011;26:516–22.PubMedCrossRefGoogle Scholar
  62. 62.
    Ada AO, Kunak SC, Hancer F, Soydas E, Alpar S, Gulhan M, et al. Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population. Mol Biol Rep. 2012;39:5985–93.PubMedCrossRefGoogle Scholar
  63. 63.
    Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.PubMedCrossRefGoogle Scholar
  64. 64.
    Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–3.PubMedCrossRefGoogle Scholar
  65. 65.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  66. 66.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  67. 67.
    Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRefGoogle Scholar
  68. 68.
    Egger M, Smith DG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of Internal MedicineLiaoning Provincial Tumor HospitalLiaoningChina

Personalised recommendations